Already in 2006, Xu et al. reported that treatment with sEH inhibitors prevented the development of cardiac hypertrophy after 3 weeks of the transverse aortic constriction in mice, and reversed the development of cardiac hypertrophy caused by chronic pressure overload [107]. Here, EPHX2 is linked to cardiac hypertrophy.